Published on
00:30 GMT
U.S. FDA may nix black box warning on some menopause estrogen treatments
If a panel convened by the U.S. Food and Drug Administration has its way, a health risk warning included in hormone treatments for symptoms of menopause may soon be removed. On July 17, FDA Commissioner Martin Makary, a longtime proponent of estrogen and …
Source:
Science News
-
Neutral
